Logo image
New search Researchers Research units
Sign in
Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy
Journal article   Open access   Peer reviewed

Euglycemic Ketoacidosis as a Complication of SGLT2 Inhibitor Therapy

Biff F Palmer and Deborah J Clegg
Clinical journal of the American Society of Nephrology, v 16(8), pp 1284-1291
Aug 2021
PMID: 33563658
url
https://cjasn.asnjournals.org/content/clinjasn/16/8/1284.full.pdfView
Published, Version of Record (VoR) Open

Abstract

Blood Glucose - metabolism Humans Ketosis - blood Ketosis - chemically induced Ketosis - physiopathology Ketosis - therapy Kidney - drug effects Kidney - physiopathology Risk Factors Sodium-Glucose Transporter 2 Inhibitors - adverse effects

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Urology & Nephrology
Logo image